Jump to Main Content

ASH Annual Meeting Abstracts

ASH Annual Meeting Abstracts

Latest Announcements

Annual Meeting attendees view and discuss an abstract.

2024 Abstract Submissions are Now Open

Abstract submissions for the 2024 ASH Annual Meeting and Exposition are now open through August 1, 2024, at 11:59 PM Pacific time. No submissions will be accepted after this deadline.

View the Call for Abstracts Page
a presenter discusses her abstract with an attendee.

ASH Introduces Changes to Abstract Submissions

Prospective abstract submitters should take note of several changes for the 2024 ASH Annual Meeting relating to the prohibition of tables and figures in abstract submissions, requests for demographic information of clinical trials, and the acknowledgement of a research integrity statement.

Read More About the Changes
Attendees watch a presenter intently during an ASH Poster Walk

2024 Poster Walk Applications are Now Open

ASH Annual Meeting Poster Walks highlight cutting-edge emerging science in hematology presented in the poster sessions during the meeting. The application deadline to conduct a poster walk is August 5, 2024, at 11:59 p.m. Pacific time.

Learn More and Apply

About ASH Annual Meeting Abstracts

Abstracts submitted for oral and poster presentation at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 7,000 scientific abstracts are submitted each year, and more than 5,000 abstracts are accepted for oral and poster presentations through an extensive peer review process.

Abstract categories are reviewed and updated annually to respond to trends and cover new areas. This year, updates include

  • The renumbering of categories (particularly those in the 600 and 900 groupings)
  • The discontinuation of two categories (731. Autologous Transplantation, and 705. Cellular Immunotherapies: Commercial and Late Stage)
  • The addition of several new categories (909. Education, Communication, and Workforce, 628. Aggressive Lymphomas: Cellular Therapies, and 655. Multiple Myeloma: Cellular therapies)
  • The splitting of several categories (including several in thrombosis and homeostasis, clinical lymphomas, and health services, quality improvement and outcomes research).

View the full list of abstract categories.

The Plenary Scientific Session, which includes the top six abstracts as selected by the Program Committee, is traditionally a highlight of the annual meeting program.

Key Dates and Deadlines

Abstract submission site opens May 30, 2024
Abstract submission deadline  August 1, 2024, 11:59 p.m. Pacific time 
Abstract withdrawal deadline September 18, 2024
Call for late-breaking abstract submissions  October 16-28, 2024 
Abstracts available online  November 5, 2024, 9:00 a.m. Eastern time 
Abstract poster presentation materials due November 12, 2024
Late-breaking abstracts available online  November 25, 2024, 9:00 a.m. Eastern time